Borrelia burgdorferiBinding of Host Complement Regulator Factor H Is Not Required for Efficient Mammalian Infection
- 1 June 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (6) , 3131-3139
- https://doi.org/10.1128/iai.01923-06
Abstract
The causative agent of Lyme disease,Borrelia burgdorferi, is naturally resistant to its host's alternative pathway of complement-mediated killing. Several different borrelial outer surface proteins have been identified as being able to bind host factor H, a regulator of the alternative pathway, leading to a hypothesis that such binding is important for borrelial resistance to complement. To test this hypothesis, the development ofB. burgdorferiinfection was compared between factor H-deficient and wild-type mice. Factor B- and C3-deficient mice were also studied to determine the relative roles of the alternative and classical/lectin pathways inB. burgdorferisurvival during mammalian infection. While it was predicted thatB. burgdorferishould be impaired in its ability to infect factor H-deficient animals, quantitative analyses of bacterial loads indicated that those mice were infected at levels similar to those of wild-type and factor B- and C3-deficient mice. Ticks fed on infected factor H-deficient or wild-type mice all acquired similar numbers of bacteria. Indirect immunofluorescence analysis ofB. burgdorferiacquired by feeding ticks from the blood of infected mice indicated that none of the bacteria had detectable levels of factor H on their outer surfaces, even though such bacteria express high levels of surface proteins capable of binding factor H. These findings demonstrate that the acquisition of host factor H is not essential for mammalian infection byB. burgdorferiand indicate that additional mechanisms are employed by the Lyme disease spirochete to evade complement-mediated killing.Keywords
This publication has 83 references indexed in Scilit:
- Borrelia burgdorferiComplement Regulator-Acquiring Surface Protein 1 of the Lyme Disease Spirochetes Is Expressed in Humans and Induces Antibody Responses Restricted to Nondenatured Structural DeterminantsInfection and Immunity, 2006
- Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan ChildrenPLoS Clinical Trials, 2006
- Evolving models of Lyme disease spirochete gene regulationWiener klinische Wochenschrift, 2006
- Relapsing Fever SpirochetesBorrelia recurrentisandB. duttoniiAcquire Complement Regulators C4b-Binding Protein and Factor HInfection and Immunity, 2006
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences, 2006
- Evidence that the BBA68 Protein (BbCRASP-1) of the Lyme Disease Spirochetes Does Not Contribute to Factor H-Mediated Immune Evasion in Humans and Other AnimalsInfection and Immunity, 2006
- Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysThe Journal of Experimental Medicine, 2006
- Loss of Complement Activation and Leukocyte Adherence asNippostrongylus brasiliensisDevelops within the Murine HostInfection and Immunity, 2005
- Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor HNature Genetics, 2002
- Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferiMedical Microbiology and Immunology, 1997